0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 36
  • 33
  • 16
  • 13
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

31
31
69
112

PUBLISHED

0
6
21
112

PRODUCT TYPE

111
1

Search for: "VaxGen Incorporated"

112 Products

Dengue - Pipeline Review, H2 2013

Dengue - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  September 2013
Price:  From

Influenza - Pipeline Review, H2 2013

Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  August 2013
Price:  From

Gene Therapy Market, 2015 - 2025

Several disorders that arise inside the body are a result of either a direct genetic aberration or a dysfunctional/non-functional protein. The attempt to use nucleic acids to correct or delete the genes...

Published:  February 2015
Price:  From

Herpes Simplex Infections - Pipeline Review, H1 2015

Herpes Simplex Infections - Pipeline Review, H1 2015 Summary This, ‘Herpes Simplex Infections - Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline. This...

Published:  March 2015
Price:  From

Dengue - Pipeline Review, H1 2013

Dengue – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  March 2013
Price:  From

Herpes Simplex Infections - Pipeline Review, H2 2013

Herpes Simplex Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Herpes Simplex Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

Published:  September 2013
Price:  From

Melanoma - Pipeline Review, H2 2013

Melanoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  August 2013
Price:  From

Allergic Rhinitis - Pipeline Review, H2 2013

Allergic Rhinitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Allergic Rhinitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  August 2013
Price:  From

HIV / AIDS – Pipeline Review, H1 2013

Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for HIV...

Published:  February 2013
Price:  From

Fallopian Tube Cancer - Pipeline Review, H1 2015

Fallopian Tube Cancer - Pipeline Review, H1 2015 Summary This, ‘Fallopian Tube Cancer - Pipeline Review, H1 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline. This report...

Published:  March 2015
Price:  From

Peritoneal Cancer - Pipeline Review, H1 2015

Peritoneal Cancer - Pipeline Review, H1 2015 Summary This, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Herpes Simplex Infections - Pipeline Review, H1 2014

Herpes Simplex Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2014’, provides an overview of the Herpes Simplex Infections’s...

Published:  March 2014
Price:  From

HIV / AIDS - Pipeline Review, H2 2013

HIV / AIDS - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  July 2013
Price:  From

Hepatitis B - Pipeline Review, H1 2013

Hepatitis B – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatitis B - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  May 2013
Price:  From

Atherosclerosis - Pipeline Review, H2 2013

Atherosclerosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Atherosclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  August 2013
Price:  From

Tuberculosis - Pipeline Review, H1 2015

Tuberculosis - Pipeline Review, H1 2015 Summary the, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Tuberculosis - Pipeline Review, H2 2014

Tuberculosis - Pipeline Review, H2 2014 Summary This, ‘Tuberculosis - Pipeline Review, H2 2014’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2014
Price:  From

Hepatitis C - Pipeline Review, H2 2013

Hepatitis C - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  August 2013
Price:  From

Dengue - Pipeline Review, H2 2012

Dengue – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  September 2012
Price:  From

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

Published:  April 2013
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC.
  • Qualcomm Incorporated
  • UBS AG